percutaneous hepatic perfusion
Showing 1 - 25 of 9,223
Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)
Not yet recruiting
- Uveal Melanoma
- Metastatic Cutaneous Melanoma
- Autologous Tumor Infiltrating Lymphocytes
- +2 more
- (no location specified)
Jun 5, 2023
Uveal Melanoma, Metastatic Trial in Leiden (Ipilimumab and nivolumab, Melphalan chemosaturation via percutaneous hepatic
Recruiting
- Uveal Melanoma, Metastatic
- Ipilimumab and nivolumab
- Melphalan chemosaturation via percutaneous hepatic perfusion
-
Leiden, Zuid-Holland, NetherlandsLeiden University Medical Center
Apr 8, 2022
Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Frankfurt, Hannover, Jena (Delcath Hepatic Delivery System,
Terminated
- Hepatocellular Carcinoma
- Intrahepatic Cholangiocarcinoma
- Delcath Hepatic Delivery System
- Melphalan
-
Frankfurt, Germany
- +2 more
Oct 13, 2022
Melanoma, Ocular Trial in Tampa, Durham (Melphalan (3 mg/kg IBW) with Hepatic Delivery System (HDS))
Available
- Melanoma, Ocular
- Melphalan (3 mg/kg IBW) with Hepatic Delivery System (HDS)
-
Tampa, Florida
- +1 more
Mar 23, 2022
Bile Duct Cancer, Intrahepatic Cholangiocarcinoma Trial in Durham, Columbus, Memphis (Melphalan/HDS, Cisplatin and Gemcitabine)
Active, not recruiting
- Bile Duct Cancer
- Intrahepatic Cholangiocarcinoma
- Melphalan/HDS
- Cisplatin and Gemcitabine
-
Durham, North Carolina
- +2 more
Mar 23, 2022
Melanoma, Ocular Trial in Worldwide (Melphalan/HDS)
Active, not recruiting
- Melanoma, Ocular
- Melphalan/HDS
-
Tucson, Arizona
- +23 more
Mar 23, 2022
Melanoma, Uveal Tumors Trial in Gothenburg (IHP)
Active, not recruiting
- Melanoma
- Uveal Neoplasms
- IHP
-
Gothenburg, SwedenSahlgrenska University Hospital
Oct 26, 2022
Uveal Melanoma, Liver Metastases Trial in Gothenburg (Isolated hepatic perfusion, Ipilimumab, Nivolumab)
Recruiting
- Uveal Melanoma
- Liver Metastases
- Isolated hepatic perfusion
- +2 more
-
Gothenburg, SwedenSahlgrenska University Hospital
May 3, 2022
Colorectal Cancer, Hepatic Metastases Trial in Tours (radiation, other, drug)
Completed
- Colorectal Cancer
- Hepatic Metastases
- MRI
- +3 more
-
Tours, FranceService d'Hépatogastro-entérologie CHRU de TOURS
Jan 6, 2023
Portal Hypertension, Non-Cirrhotic Portal Hypertension, Non-Cirrhotic Portal Fibrosis Trial in Rio de Janeiro (Hepatic vein
Not yet recruiting
- Portal Hypertension
- +9 more
- Hepatic vein pressure gradient measurement
- +2 more
-
Rio de Janeiro, RJ, BrazilHospital Universitário Clementino Fraga Filho / Universidade Fed
Jan 30, 2023
Hepatic Carcinoma Trial in Guangzhou (NanoKnife LEDC System)
Completed
- Hepatic Carcinoma
- NanoKnife LEDC System
-
Guangzhou, Guangdong, ChinaFUDA Cancer Hospital
Sep 1, 2021
Hepatic Carcinoma Trial in Guangzhou (NanoKnife)
Completed
- Hepatic Carcinoma
- NanoKnife
-
Guangzhou, Guangdong, China中国
Sep 1, 2021
Carotid Artery Stenosis, Carotid Artery Stenting, Stroke Trial in Wroclaw (procedure, diagnostic test, radiation, other)
Not yet recruiting
- Carotid Artery Stenosis
- +2 more
- CAS + Intravascular measuring the pressure gradient
- +6 more
-
Wrocław, Dolnośląskie, Poland4th Military Hospital
Nov 3, 2023
Hepatocellular Carcinoma Trial in Bobigny (Interact Active Tracker)
Recruiting
- Hepatocellular Carcinoma
- Interact Active Tracker
-
Bobigny, FranceSERROR
Sep 27, 2021
Hepatocellular Carcinoma, Chemo Effect, Chemotherapeutic Toxicity Trial in Guangzhou (Oxaliplatin,calcium folinic acid,
Recruiting
- Hepatocellular Carcinoma
- +2 more
- Oxaliplatin,calcium folinic acid, levofolinic acid, 5-FU
- +4 more
-
Guangzhou, Guangdong, ChinaSUN Yat-sen University Cancer Center
Sep 11, 2023
Coronary Disease, Percutaneous Coronary Intervention, Exercise Test Trial in New Haven (No study intervention)
Enrolling by invitation
- Coronary Disease
- +4 more
- No study intervention
-
New Haven, ConnecticutYale University School of Medicine - Section of Cardiology
Nov 9, 2022
Intraocular Melanoma, Melanoma (Skin), Metastatic Cancer Trial in United States (melphalan, regional chemo, systemic chemo)
Completed
- Intraocular Melanoma
- +2 more
- melphalan
- +3 more
-
Santa Monica, California
- +11 more
Jun 15, 2021
Hepatocellular Carcinoma Trial in Toronto (CT perfusion, Norepinephrine intra-arteriel/hepatic)
Completed
- Hepatocellular Carcinoma
- CT perfusion
- Norepinephrine intra-arteriel/hepatic
-
Toronto, Ontario, CanadaToronto General Hospital
Apr 26, 2021
Hepatic Tumor Trial in Montpellier, Villejuif (The Quantum Surgical device)
Completed
- Hepatic Tumor
- The Quantum Surgical device
-
Montpellier, France
- +1 more
Feb 3, 2021
Mean Platelet Volume and STEMI Clinical Risk Scores in
Recruiting
- No-Reflow Phenomenon
- Mean platelet volume, lymphocyte number, STEMI clinical risk scores
-
Assiut, EgyptAssiut university hospital
Mar 2, 2021
Coronary Stenosis Trial in Canada, United States (Ringer Perfusion Balloon Catheter)
Recruiting
- Coronary Stenosis
- Ringer Perfusion Balloon Catheter
-
Torrance, California
- +6 more
Feb 2, 2023
Colorectal Cancer Trial in Shanghai (HAIC, Fruquintinib, Tislelizumab)
Recruiting
- Colorectal Cancer
- HAIC
- +5 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 15, 2022
Ischemic Heart Disease Trial in New York (Revascularization by Coronary Artery Bypass Graft or Percutaneous Coronary
Recruiting
- Ischemic Heart Disease
- Revascularization by Coronary Artery Bypass Graft or Percutaneous Coronary Intervention
-
New York, New YorkGramercy Cardiac Diagnostic Services
Aug 17, 2021
Percutaneous Transluminal Angioplasty for Peripheral Artery
Recruiting
- Peripheral Artery Disease (PAD)
-
Guangzhou, Guangdong, ChinaFangge Deng
Jul 16, 2023
Internal Endoscopic Versus Percutaneous Drainage in Biliary
Recruiting
- Biliary Obstruction
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 9, 2023